Compare ADMA Biologics Inc (ADMA) vs Marqeta Inc (MQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Marqeta Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Marqeta Inc trades at $15.52 (market cap $1.62B). The key difference: ADMA Biologics Inc is the larger of the two by market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Marqeta Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | MQ | |
|---|---|---|
Market Cap | $2.22B | $1.62B |
Sector | Health | Technology |
52-Week High | $20.38 | $26.00 |
52-Week Low | $7.60 | $15.04 |
Enterprise Value | $2.29B | $935.36M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →
